Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA). - Wikidata - wikimedia - TriplyDB

Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).

Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).

http://www.wikidata.org/entity/Q34566243

about

Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).

P2860

Q42245817-56EFE5B3-24A9-44C9-B16F-7169C59519A2 Q43231683-E17DCE3A-DBC6-4538-8FAB-A96A9DD24047

P2860

Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).

http://www.wikidata.org/entity/Q34566243

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@ast

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@en

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@nl

type

label

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@ast

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@en

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@nl

prefLabel

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@ast

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@en

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@nl

P1433

Q34566243-99835D58-0FE9-4339-BF0A-FAC6D881A28F

P1476

Q34566243-1E0D7120-4B88-4F7C-BE0F-36B665F105B6

P2093

Q34566243-18F89A3B-27B8-41F1-A322-103CFFCF20BA

Q34566243-1DC4157E-AA05-487E-9E54-C43F95EF201E

Q34566243-246D41B8-1E4F-47E5-BBC6-F132304A70A5

Q34566243-2D39D2DF-B3D7-4AB7-BC08-B15F86DEFE0D

Q34566243-31CA3283-A60D-4C75-B7D3-816D4A8F90F7

Q34566243-654325BD-2AFB-4C8D-A5E9-DE5B917B18EA

Q34566243-77C45DEE-4B03-4F48-AA34-9E5526C1CC0F

Q34566243-8A3ED223-0290-4AF0-ADEE-828DDAE4E0FA

Q34566243-900788BC-FBCF-4A26-A0B3-B09FBAE53371

Q34566243-918999B6-137C-4DB2-ABF8-97BCA3C4B2B7

P2860

Q34566243-13147850-DDC9-4FB9-8CD5-3045505021DE

Q34566243-1C09406D-49B0-4FB9-B228-4FFB761BE195

Q34566243-1F35989B-D456-4E78-A806-14C03D9BBC59

Q34566243-20971EF4-94B7-4AEB-B8DB-34761F2E8E20

Q34566243-27C16C27-25CB-4C69-88B0-61D34C351738

Q34566243-2D0AFE37-2EA1-4F71-870E-54E10E319A42

Q34566243-2F496C20-3E41-4FF8-A4BC-73C76AC68196

Q34566243-3072413B-1A8A-48A5-9A49-798E99B25ADD

Q34566243-40E652A8-0736-4049-B9CC-D7E988707CAB

Q34566243-44E9756F-3178-451E-AF5D-61DC5A5161D0

P304

Q34566243-20BA6854-BBAD-41D1-959C-FD52C4F0391A

P31

Q34566243-773916BD-D7DB-49AC-94DE-2C7015F97DBA

P356

Q34566243-DC2F0A5C-D0AD-461C-B9B2-F1750487782B

P407

Q34566243-07740C26-E730-45A7-8134-149AD211339F

P433

Q34566243-27851FBE-577D-4AEA-893A-88472032304F

P478

Q34566243-80AFB1B8-432B-4169-B108-80FA2FA814B8

P50

Q34566243-7692054F-07A6-437C-9EF2-3E9BBE20F0D9

P577

Q34566243-9109722D-2842-4B2C-BDA6-1C45C991EE6E

P5875

Q34566243-C67FD076-8138-4615-AA74-8AD7A2F7A900

P698

Q34566243-692CBB91-6E6F-444E-A128-215699FCE11D

P921

Q34566243-2E3B3FD8-32DD-480C-8FAA-CD001C521BB0

Q34566243-C5D8E1A0-BB0D-40F5-B6B3-50E1DDC99221

P932

Q34566243-5D7F922A-E9FB-425D-8099-D6A0E0BB5729

P356

JOURNAL.PONE.0113933

P1433

P1476

Observational study assessing ...... interferon beta-1b (EXTAVIA).

@en

P2093

Athanasios Kyritsis

http://www.w3.org/2001/XMLSchema#string

Christos Giannoulis

http://www.w3.org/2001/XMLSchema#string

Clementine Karageorgiou

http://www.w3.org/2001/XMLSchema#string

Damianos Petrou

http://www.w3.org/2001/XMLSchema#string

Dimitra Papadimitriou

http://www.w3.org/2001/XMLSchema#string

Dimitrios Georgiopoulos

http://www.w3.org/2001/XMLSchema#string

Efthimios Dardiotis

http://www.w3.org/2001/XMLSchema#string

Elias Zintzaras

http://www.w3.org/2001/XMLSchema#string

Evaggelos Kouremenos

http://www.w3.org/2001/XMLSchema#string

Georgios Hadjigeorgiou

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term follow-up of clinical trials of multiple sclerosis therapies

Perceived needs and satisfaction with care in people with multiple sclerosis: a two-year prospective study

Evidence for a two-stage disability progression in multiple sclerosis

The importance of physician-patient relationship for improvement of adherence to long-term therapy: data of survey in a cohort of multiple sclerosis patients with mild and moderate disability.

Health care utilization by people with multiple sclerosis in The Netherlands: results of two separate studies.

Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).

Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis.

Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium)

Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command.

P304

e113933

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0113933

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Despoina Mademtzoglou

P577

2014-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268786365

http://www.w3.org/2001/XMLSchema#string

P698

25419842

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

4242657

http://www.w3.org/2001/XMLSchema#string